🇺🇸 FDA
Patent

US 10220022

Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone

granted A61KA61K31/404A61K31/4184

Quick answer

US patent 10220022 (Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone) held by The Regents of the University of California expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/404, A61K31/4184, A61K31/428, A61K31/429